课题基金 / 基金详情

项目摘要

项目成果

Eugene Krentsel的其他基金

相似基金

相关文献

中文摘要
翻译
东南XLerator网络建议创建一个网络化和易于访问的区域
英文摘要
The Southeast XLerator Network proposes to create a networked and easily accessible regional technology transfer accelerator hub (“XLerator Hub” or “Hub”) to share best practices, disseminate education content, and offer products, services, facilities and other resources connected through both physical and online platforms for innovators and trainees in the Southeast IDeA states. Led by XLerateHealth, LLC, an SBA award-winning healthcare-focused technology accelerator, the Hub will 1) bridge the divide between great ideas and the marketplace by leveraging and connecting existing resources and unique expertise assets across all participating entities in the Southeast IDeA state region, 2) fill the gaps that constitute barriers to efficient commercialization among partner institutions, and 3) deliver the necessary resources, education, and business networks to foster and sustain a culture of entrepreneurship across the region. This project will address significant disparities and lack of access to resources, talent and capital in respective local commercialization ecosystems for biomedical technologies that are pervasive across the Southeast IDeA state region, making the rates of technology transfer and commercialization of academic research discoveries in this region suboptimal. The Hub objectives/ core functions are: 1. To improve knowledge and understanding by innovators about how technologies are brought to market. 2. To improve knowledge and understanding by accelerators and technology transfer offices about the unique commercialization pathways of various biomedical technologies 3. To facilitate access to technology/product development and commercialization resources required for early-stage technology advancement and later-stage product development 4. To help close the gap(s) in funding (a) between basic research discoveries and scientific proof of feasibility, and (b) between exhaustion of grant funding and private capital required to generate products and revenues. 5. To commercialize new innovation in pharmaceuticals, medical devices, healthcare IT and electronics, and other biomedical technologies through entrepreneurship, licensing and partnerships with established companies, and additionally commercialize the Hub’s platform, programs, and materials through access by other regions. The impact of the Hub will be increased market-ready technologies and patents, more successful startups, and increased biomedical technology acceleration.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Characterization and Optimization of Injectable In Situ Crosslinked Chitosan-Genipin Hydrogels.
可注射原位交联壳聚糖-京尼平水凝胶的表征和优化。
DOI: 10.1002/mabi.202200505
发表时间: 2023
期刊: Macromolecular bioscience
影响因子: 4.6
作者: [Priddy-Arrington,TylerR, Edwards,ReaganE, Colley,ClaireE, Nguyen,MarissaM, Hamilton-Adaire,Tess, Caldorera-Moore,MaryE]
通讯作者: Caldorera-Moore,MaryE
DOI: 10.3390/ijms22073752
发表时间: 2021-04-04
期刊: International journal of molecular sciences
影响因子: 5.6
作者: [Ye Q, Mohamed R, Dakhlallah D, Gencheva M, Hu G, Pearce MC, Kolluri SK, Marsh CB, Eubank TD, Ivanov AV, Guo NL]
通讯作者: Guo NL
I-RED Southeast XLerator Network
  • 批准号:
    10779668
  • 项目类别:
  • 资助金额:
    $149.48万
  • 财政年份:
    2023
  • 负责人:
    Eugene Krentsel
  • 依托单位:
I-RED Southeast XLerator Network
  • 批准号:
    10546610
  • 项目类别:
  • 资助金额:
    $25.2万
  • 财政年份:
    2022
  • 负责人:
    Eugene Krentsel
  • 依托单位:
I-RED Southeast XLerator Network: Business Fundamentals for Core Facility Directors
  • 批准号:
    10684493
  • 项目类别:
  • 资助金额:
    $8.3万
  • 财政年份:
    2022
  • 负责人:
    Eugene Krentsel
  • 依托单位:
海外基金